发明名称 |
TIMP3 as VEGF inhibitor |
摘要 |
Polypeptides or proteins comprising tissue inhibitor of mettaloproteinases-3 (TIMP3) or variants of TIMP3 can be used to substantially inhibit vascular endothelial growth factor (VEGF) binding to VEGF receptor-2 (VEGFR2/KDR/Flk-1)) without substantially inhibiting VEGF binding to VEGF receptor 1 (VEGFR1/Flt-1). |
申请公布号 |
US9498509(B2) |
申请公布日期 |
2016.11.22 |
申请号 |
US200711653647 |
申请日期 |
2007.01.16 |
申请人 |
The Cleveland Clinic Foundation |
发明人 |
Anand-Apte Bela |
分类号 |
A61K38/17;C07K14/00;C07K14/47;A61K48/00;A61K38/00 |
主分类号 |
A61K38/17 |
代理机构 |
Tarolli, Sundheim, Covell & Tummino LLP |
代理人 |
Tarolli, Sundheim, Covell & Tummino LLP |
主权项 |
1. A method of inhibiting VEGF induced endothelial cell proliferation and/or migration in a population of VEGFR2 expressing endothelial cells in the presence of VEGF, the method comprising:
administering to the VEGFR2 expressing endothelial cells a polypeptide comprising a fragment of TIMP3 that includes SEQ ID NO: 9, wherein the polypeptide is effective to inhibit endothelial cell proliferation and/or migration in the population of VEGFR2 expressing endothelial cells and wherein the polypeptide is free of metalloproteinase inhibiting activity. |
地址 |
Cleveland OH US |